Telehealth flexibilities were expanded during the COVID-19 pandemic to facilitate access to the medications for opioid use disorder (MOUD) for individuals in treatment for opioid use disorder (OUD).
A new study in JAMA Psychiatry found that individuals with OUD that received OUD treatment via telehealth were more likely to stay in treatment and less likely to be treated for an overdose.
This exploratory longitudinal cohort study was led by researchers from the Centers for Disease Control and Prevention, National Institutes of Health, and Centers for Medicare & Medicaid Services (CMS) and included data from 175,778 CMS beneficiaries.
For more information on using telehealth for OUD treatment and other behavioral health services see:
- AHRQ Academy: Telehealth and Behavioral Health Integration